English  |  正體中文  |  简体中文  |  Total items :2854037  
Visitors :  45390128    Online Users :  1601
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

Jump to a point in the index:
Or type in a year:
Show Most Recent First Ordering With Oldest First

Showing items 2235451-2235475 of 2346973  (93879 Page(s) Totally)
<< < 89414 89415 89416 89417 89418 89419 89420 89421 89422 89423 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-09-04T06:11:16Z How have the recent advances in antiviral therapy impacted the management of virus-related hepatocellular carcinoma? Wang C.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:16Z Perspectives on dual hepatitis B and C infection in Taiwan Liu C.-J.; Chen P.-J.; Chen D.-S.; Tseng T.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:17Z Faldaprevir, pegylated interferon, and ribavirin for treatment-na?ve HCV genotype-1: Pooled analysis of two phase 3 trials Jensen D.M.; Asselah T.; Dieterich D.; Foster G.R.; Sulkowski M.S.; Zeuzem S.; Mantry P.; Yoshida E.M.; Moreno C.; Ouzan D.; Wright M.; Morano L.E.; Buynak R.; Bourli?re M.; Hassanein T.; Nishiguchi S.; JIA-HORNG KAO; Omata M.; Paik S.W.; Wong D.K.; Tam E.; Kaita K.; Victor Feinman S.; Stern J.O.; Scherer J.; Quinson A.-M.; Voss F.; Gallivan J.-P.; B?cher W.O.; Ferenci P.
臺大學術典藏 2021-09-04T06:11:17Z Hepatitis B surface antigen loss and hepatocellular carcinoma development in patients with dual hepatitis B and C infection Yang W.-T.; Wu L.-W.; Tseng T.-C.; Chen C.-L.; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Liu C.-J.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:17Z Daclatasvir-containing all-oral regimens for the treatment of hepatitis C virus infection Yang S.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:18Z Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan Wang C.-C.; Lin C.-L.; Hsieh T.-Y.; Tseng K.-C.; Peng C.-Y.; Su T.-H.; Yang S.-S.; Hsu Y.-C.; Chen T.-M.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:18Z Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study Su T.-H.; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; Chen P.-J.; Chen D.-S.; Chen C.-L.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:18Z Hepatitis C virus infection in Taiwan: Past, present, and future JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:19Z HIV/HCV coinfection in Taiwan Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:19Z Hepatocellular carcinoma recurrence after interferon-free direct acting antiviral treatment for chronic hepatitis C virus infection: Fact or fiction? Liu C.-H.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:19Z New perspectives of biomarkers for the management of chronic hepatitis B Lin C.-L.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:19Z Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update Sarin S.K.; Kumar M.; Lau G.K.; Abbas Z.; Chan H.L.Y.; Chen C.J.; Chen D.S.; Chen H.L.; Chen P.J.; Chien R.N.; Dokmeci A.K.; Gane E.; Hou J.L.; Jafri W.; Jia J.; Kim J.H.; Lai C.L.; Lee H.C.; Lim S.G.; Liu C.J.; Locarnini S.; Al Mahtab M.; Mohamed R.; Omata M.; Park J.; Piratvisuth T.; Sharma B.C.; Sollano J.; Wang F.S.; Wei L.; Yuen M.F.; Zheng S.S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:20Z Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma model Li Y.-T.; Liu C.-J.; Su T.-H.; Cheng H.-R.; Jeng Y.-M.; Lin H.-L.; Wang C.-C.; JIA-HORNG KAO; Chen P.-J.; Chen D.-S.; Wu H.-L.
臺大學術典藏 2021-09-04T06:11:20Z Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis Yang H.-I.; Tseng T.-C.; Liu J.; Lee M.-H.; Liu C.-J.; Su T.-H.; Batrla-Utermann R.; Chan H.L.Y.; JIA-HORNG KAO; Chen C.-J.
臺大學術典藏 2021-09-04T06:11:21Z Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study Liu C.-H.; Sheng W.-H.; Sun H.-Y.; Hsieh S.-M.; Lo Y.-C.; Liu C.-J.; Su T.-H.; Yang H.-C.; Liu W.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:21Z Looking into the crystal ball: biomarkers for outcomes of HBV infection Yang H.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:21Z Hepatitis B virus: New therapeutic perspectives Lin C.-L.; Yang H.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:21Z Can noninvasive biomarkers replace liver biopsy for chronic hepatitis B? Lin C.-L.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:22Z Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Na?ve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; JIA-HORNG KAO; Yu M.-L.
臺大學術典藏 2021-09-04T06:11:22Z Artificial ascites is feasible and effective for difficult-to-ablate hepatocellular carcinoma Wang C.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:23Z Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: A nation-wide cohort study Huang Y.-W.; Wang T.-C.; Yang S.-S.; Lin S.-Y.; Fu S.-C.; Hu J.-T.; Liu C.-J.; JIA-HORNG KAO; Chen D.-S.
臺大學術典藏 2021-09-04T06:11:23Z Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial Liu C.-H.; Liu C.-J.; Huang C.-F.; Lin J.-W.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Lee C.-Y.; Chen S.-I.; Yang S.-S.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:23Z Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers Tseng T.-C.; Liu C.-J.; Yang H.-C.; Chen C.-L.; Yang W.-T.; Tsai C.-S.; Kuo S.F.-T.; Verbree F.C.; Su T.-H.; Wang C.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:24Z Towards an HBV cure: State-of-the-art and unresolved questions-report of the ANRS workshop on HBV cure Zeisel M.B.; Lucifora J.; Mason W.S.; Sureau C.; Beck J.; Levrero M.; Kann M.; Knolle P.A.; Benkirane M.; Durantel D.; Michel M.-L.; Autran B.; Cosset F.-L.; Strick-Marchand H.; Tr?po C.; JIA-HORNG KAO; Carrat F.; Lacombe K.; Schinazi R.F.; Barr?-Sinoussi F.; Delfraissy J.-F.; Zoulim F.
臺大學術典藏 2021-09-04T06:11:24Z A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan Bennett H.; Waser N.; Johnston K.; JIA-HORNG KAO; Lim Y.-S.; Duan Z.-P.; Lee Y.-J.; Wei L.; Chen C.-J.; Sievert W.; Yuan Y.; Li H.

Showing items 2235451-2235475 of 2346973  (93879 Page(s) Totally)
<< < 89414 89415 89416 89417 89418 89419 89420 89421 89422 89423 > >>
View [10|25|50] records per page